Clinical Trial Update: Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating zoledronic acid as adjuvant therapy for neovascular age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Oslo University Hospital | Conditions: Neovascular Age-related Macular Degeneration | Phase 2 | Status: COMPLETED